**Core Concept**
Lysosomal storage diseases are a group of disorders caused by the accumulation of toxic substances within lysosomes due to enzyme deficiencies. These diseases can affect various tissues, including the nervous system, and are often characterized by the accumulation of abnormal substances that disrupt cellular function.

**Why the Correct Answer is Right**
Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by the deficiency of the enzyme arylsulfatase A (ARSA). This enzyme is responsible for breaking down sulfatides, which are lipids that are a component of myelin. In MLD, the accumulation of sulfatides within lysosomes leads to the degeneration of myelin, resulting in demyelination and the disruption of nerve conduction. The abnormal myelin synthesis is a hallmark of this disease, leading to progressive neurological deterioration.

**Why Each Wrong Option is Incorrect**
**Option A:** Krabbe disease is another lysosomal storage disease that affects myelin, but it is caused by the deficiency of galactocerebroside beta-galactosidase, not arylsulfatase A.

**Option B:** Fabry disease is a lysosomal storage disease that affects various tissues, but it is caused by the deficiency of alpha-Gal A, not related to myelin synthesis.

**Option C:** Tay-Sachs disease is a lysosomal storage disease that affects the nervous system, but it is caused by the deficiency of hexosaminidase A, not related to myelin synthesis.

**Clinical Pearl / High-Yield Fact**
Lysosomal storage diseases can be classified into different categories based on the type of substance accumulated within lysosomes, including glycoproteins, glycolipids, and mucopolysaccharides. Understanding the specific enzyme deficiency and the accumulated substance is crucial for diagnosing and managing these diseases.

**Correct Answer:** C. Metachromatic leukodystrophy.